Tag: Bapineuzumab

Childhood migraine associated with infantile colic

Bapineuzumab does not improve clinical outcomes in Alzheimer’s disease

bys25qthea

January 26, 2014

Image: PD 1. Bapineuzumab, a humanized anti-Aβ monoclonal antibody, did not improve clinical outcomes in patients with mild-to-moderate Alzheimer’s disease. ...

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

2 Minute Medicine: Pharma Roundup- Obesity RNA deal, at-home Alzheimer’s dosing, oncology royalty financing, and first Bruton’s Tyrosine Kinase Inhibitor for Immune Thrombocytopenia [September 3, 2025]
Menin inhibition with revumenib for NPM1-mutated relapsed or refractory acute myeloid leukemia: the AUGMENT-101 study
An absence of cardiovascular risk factors is linked to over ten additional healthy years

No Result

View All Result